Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A California startup says its at-home test could help couples decide if the fertility treatment is worth trying.
Illumina wants a greater part of the reproductive-health market, says CEO Jay Flatley.
A study involving higher-resolution genetic screening suggests that healthy embryos may be wasted during IVF.
New noninvasive screening techniques aim to identify the healthiest embryos.
New embryo-screening technologies could weed out embryos with major genetic abnormalities and improve IVF success rates.